Cargando…

Correction: Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711458/ https://www.ncbi.nlm.nih.gov/pubmed/31523720 http://dx.doi.org/10.1136/bmjophth-2019-000322corr1

Ejemplares similares

Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial
por: Srinivasan, Sathish, et al.
Publicado: (2019)

Experiences with the Scharioth Macula Lens – new hope for patients with dry macular degeneration
por: Bereczki, Árpád
Publicado: (2019)

Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study
por: Kremláček, Jan, et al.
Publicado: (2021)

Scharioth Macula Lens for patients with high myopia: a novel approach to achieve spectacle independence (binocular trifocal monovision)
por: Scharioth, Gabor Bernd, et al.
Publicado: (2023)

Modified Scharioth's technique of scleral fixation of intraocular lens
por: Roop,, et al.
Publicado: (2017)

Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration
por: Suzuki, Mihoko, et al.
Publicado: (2007)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Correction to: Influence of Postoperative Posture on Macular Slippage after Macula-Off Retinal Detachment: A Randomized Controlled Trial
por: Schawkat, Megir, et al.
Publicado: (2020)

Correction: Utility values for age-related macular degeneration patients in Korea
por: Choi, Seulggie, et al.
Publicado: (2018)

Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
por: Okada, Kyoko, et al.
Publicado: (2009)

Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi, Hidenori, et al.
Publicado: (2018)

Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula
por: Curcio, Christine A.
Publicado: (2018)

Correction: High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Visual outcomes of macula-involving rhegmatogenous retinal detachment in patients with and without age-related macular degeneration
por: Paulk, P. Barrett, et al.
Publicado: (2022)

Correction: Aspirin Use and Risk of Age-Related Macular Degeneration: A Meta-Analysis
por: Zhu, Wei, et al.
Publicado: (2013)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Correction: ‘You’ve got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration
por: Taylor, Deanna J., et al.
Publicado: (2019)

Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration
por: Clark, Simon J., et al.
Publicado: (2014)

Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
por: Riemer, Tommes, et al.
Publicado: (2023)

Correction to: Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis
por: Skelly, Adrian, et al.
Publicado: (2022)

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
por: Yanagi, Yasuo, et al.
Publicado: (2023)

Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach
por: Fraccaro, Paolo, et al.
Publicado: (2015)

Macula Ganglion Cell Thickness Changes Display Location-Specific Variation Patterns in Intermediate Age-Related Macular Degeneration
por: Trinh, Matt, et al.
Publicado: (2020)

Correction: Age-Related Macular Degeneration and the Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis
Publicado: (2014)

Correction to: Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration
por: Jones, Rebecca, et al.
Publicado: (2023)

Correction: Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study
por: Ricci, Federico, et al.
Publicado: (2013)

Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens
por: Jiang, Bo, et al.
Publicado: (2022)

What about the fellow eye in treatment of neovascular age‐related macular degeneration? Analysis of data from the Swedish macula register
por: Lövestam Adrian, Monica, et al.
Publicado: (2022)

Correction: Circulating insulin-like growth factor-1: a new clue in the pathogenesis of age-related macular degeneration
por: Castellino, Niccolò, et al.
Publicado: (2019)

Correction: Association between NF-kB polymorphism and age-related macular degeneration in a high-altitude population
por: Xin, Yan, et al.
Publicado: (2022)

Correction: Postoperative choroidal vascularity index after the management of macula-off rhegmatogenous retinal detachment
por: Quiroz-Reyes, Miguel A., et al.
Publicado: (2023)

Author Correction: Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10
por: Zouache, Moussa A., et al.
Publicado: (2021)

Correction: Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
Publicado: (2015)

Correction to: Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)
por: Yadav, Monika, et al.
Publicado: (2020)

One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study
por: Hjelmqvist, Lars, et al.
Publicado: (2011)

Correction: A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
por: Sivakumaran, Theru A., et al.
Publicado: (2018)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7re5dnaiu75e047t7tebjull17